TrialDiabetes & metabolism journal2026
Glycemic Benefit of Insulin Degludec/Insulin Aspart Compared to Basal Insulin in Type 2 Diabetes Mellitus Associated with Impaired Glucagon-Like Peptide-1 Response: A Randomized Crossover Trial.
Han Na Jang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.